Clinical Focus
Previous Articles Next Articles
Online:
Published:
Contact:
Abstract: Objective To systematically evaluate the relationship between the carotid atherosclerotic plaque and the serum chitin enzymes protein 40 (YKL 40) level in patients with atherosclerotic cerebral infarction (ACI). Methods Literature about the influence of serum YKL 40 levelonACIpublished before Jan.1, 2018 were searched. The search was conducted in databases including CNKI, Wanfang Dataand PubMed. The casecontrol study about the YKL40 levelbetween ACI patients(ACI group) and patients without ACI(control group) were included in this study. Quality evaluation and data extraction were carried out, and meta analysis was performed by RevMan 5.3.Results Sevencasecontrol studies were included in this study, including 649 patients in the ACI group and 290patientsin the control group. The result showed that the serum YKL 40 level of the ACI group were much more higher than that of thecontrol group, and the differences is statistically significant (SMD=1.55,95%CI=1.391.71,P<0.01); In the ACI group, the serum YKL 40 level among patientswith stable plaques was lower than that of patients withunstable plaques. Conclusion The level of serum YKL40 is positively correlated with the occurrence of ACI in China, and the higher the serum YKL40 is, the worse the stability of atherosclerotic plaques is.
Key words: brain , infarction, atherosclerosis;chitin enzymes protein;meta analysis
Yan Wen, Sun Bo, Ren Jiangong. Metaanalysis of the relationship between carotid atherosclerotic plaque and serum YKL 40 level in atherosclerotic cerebral infarction patients[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.08.013.
Add to citation manager EndNote|Ris|BibTeX
URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2018.08.013
https://lchc.magtechjournal.com/EN/Y2018/V33/I8/700